Published date: 13 February 2020

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 24 February 2020

Contract summary

Industry

  • Health and social work services - 85000000

Location of contract

East Midlands, East of England, London, North East, North West, South East, South West, West Midlands, Yorkshire and the Humber

Value of contract

£0 to £1

Procurement reference

20200213174109-68205

Published date

13 February 2020

Closing date

24 February 2020

Contract start date

1 November 2020

Contract end date

31 March 2025

Contract type

Service contract

Procedure type

Not applicable

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No


Description

EU Supply Reference - Quote/tender 39021

Description of the procurement opportunity:

NHS England Specialised Commissioning (The Commissioner) is planning to commission organisations to provide the Thrombotic Thrombocytopenic Purpura (TTP) for the population of England.

This notice is to advise prospective providers of the Commissioner's intention, and opportunities to engage and participate in a dedicated WebEx Market Engagement Event.

TTP is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate (and in the case of congenital TTP, ongoing) management in a centre with comprehensive provision and a multi-discipline approach. Specialist led co-ordinated care is key to improving outcomes for this patient group.

The service objectives are to:
• Improve the identification of patients with this disease
• Improve the time to treatment and management of the patients and improve their outcomes.
• Provide a specialised centre that can provide expert led care
• Reduce the mortality from this disease
• Ensure patients have a positive experience of care
• Manage the ongoing long-term care and potential relapse
• Maintain and encourage patients own family/friend support (patient led)
• Improve times from diagnosis to treatment including bed availability, line insertion and start of apheresis
• Ensure infrastructure of staff to undertake this process e.g. consultant haematologists and CNS
• Ensure dedicated PAs by a clinical psychologist to support in patient care and outpatient follow up to capture depression/anxiety (in approximately 50% patients) and support return to normal activities pre TTP.
• Support patient groups who will also carry out independent patient satisfaction exercises and invite them to join the national annual Highly Specialised audit meeting to present this work to other services and commissioners.
• At the Highly Specialised Service annual clinical meeting identify changes in the service based on patient feedback.

Market Engagement Event:

The Commissioner is intending to engage with interested healthcare providers through:

o WebEx Market engagement event
Interested organisations are invited to attend a market engagement event which will take place on Monday 24 February 2020, 14.00 to 15.00 GMT via WebEx.

o Joining instructions and draft agenda
For more information, WebEx joining instructions and draft agenda please refer to Document 1 - Invitation TTP Market engagement event available on the EU Supply portal (Quote/tender 39021).


About the buyer

Contact name

Neli Garbuzanova

Address

10 Nottingham Road
Derby
DE13QT
ENG

Email

neli.garbuzanova@nhs.net

Website

https://www.ardengemcsu.nhs.uk/